Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.
Nexcelom's China team works with scientists in State Key Laboratory of Respiratory Diseases in China, for the screening of antiviral agents against SARS-CoV-2 virus, the cause of COVID-19 (Corona Virus).
This webinar examines specific virology related assays such as plaque and foci formation, as well as antibody neutralization.
This webinar examines specific virology related assays such as plaque and foci formation, as well as antibody neutralization.
Therapeutic Potential of HIV Protease-Activable CASP3 Authors: Kosuke Miyauchi, Emiko Urano, Mari Takizawa, Reiko Ichikawa, Jun Komano Scientific Reports 2012; 2: 359; doi:10.1038/srep00359. Background: As the primary executioner caspase involved in apoptosis, Caspase-3 is a key therapeutic target in cancer cells exhibiting uncontrolled cell proliferation. Because Caspase-3 activation is highly regulated, development of a viable treatment method has been difficult. Recent gene therapy procedures have been effective against HIV-1 infection, but development of treatment resistance due to mutation is a problem. Negative effects on healthy cells is also a problem. […]
